• About
  • Privacy Policy
  • Cookie Policy
  • Terms of Use 
  • My account
  • Contact
Wednesday, September 17, 2025
  • Login
Arab Health World
Advertisement
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit
No Result
View All Result
Arab Health World
No Result
View All Result
  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact
Home Sectors

Digital Health’s monthly roundup of contracts and go lives

admin by admin
April 9, 2023
in Sectors
0
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Our latest roundup of contracts and go lives brings you news of Wellola’s patient communication platform going live in Birmingham and The Christie NHS Foundation Trust becoming the first specialist cancer trust to deploy CardMedic.

Radar Healthcare partners with Circle Health Group

In January we saw the news that Radar Healthcare is set to supply the UK’s largest private hospital group with risk management and compliance software to help improve patient outcomes.

Currently, Circle Health Group’s 54 hospitals use multiple risk management and compliance systems. Radar Healthcare will supply one integrated platform to improve efficiency and unlock vital safety data that will help to improve overall performance.

Integration of the Radar Healthcare platform across Circle Health Group started last month. Its deployment will allow the private hospital company to evolve its current processes. In addition, it will support compliance to the Learn from Patient Safety Events (LFPSE) service.

Nottingham University Hospitals rolls out Nervecentre EPMA

In the final week of January, Nottingham University Hospitals NHS Trust announced it has advanced its Digitisation Programme with the rollout of the Nervecentre EPMA, which will improve patient safety through the reduction of medication errors.

The e-prescribing and medicines administration (EPMA) from Nervecentre provides a safe and efficient closed-loop solution for clinicians. It allows GS1 barcode scanning of patient wristbands and medicines from a mobile device used at the patient’s bedside.

As well as limiting the potential for medication errors, the system is also enabling clinical decision support and delivering time-savings and workflow efficiencies.

According to Nottingham University Hospitals, its use within the cardiology department has resulted in the time taken for discharge summaries to drop to under 10 minutes, from the previous 40+ minutes.

Wellola’s patient communication platform to go live in Birmingham

Birmingham Community Healthcare NHS Foundation Trust (BCHC) is to go-live with Wellola’s patient communication platform, Portasana, to help the trust meet national targets for reducing waiting list backlogs.

The new platform will digitise up to two million patient communications every year. The hope is that it will help to reduce the number of missed appointments or Did Not Attends (DNAs) in the Birmingham region, whilst freeing up workplace capacity by automating patient communications.

Patients will be able to access Wellola’s Portasana platform either from BCHC’s website or via an app. They will be able to view their appointments, medical records and healthcare letters plus access educational resources provided by their clinician.

The second phase of the rollout – set to happen early this year – will also give patients the functionality to cancel and reschedule appointments, fill in online assessments and access virtual care pathways.

Warrington and Halton integrates EPR with GP connect

The first week of February saw Warrington and Halton Teaching Hospitals NHS Foundation Trust going live with the integration of its electronic patient record (EPR) with NHS Digital’s GP Connect products.

As a result, clinicians using Dedalus’ EPR can now view key clinical information from GP systems in the hospital’s EPR at the point of care.

Healthcare professionals at the trust can securely access GP medication and allergy records. They can also view and import a patient’s current medication status. This additional information supports ongoing treatment decisions, improving both care and patient outcomes.

The Christie becomes first specialist cancer trust to deploy CardMedic

The early days of this month also saw The Christie NHS Foundation Trust deploying CardMedic to help reduce health inequalities for patients, making it the first specialist cancer trust to use the healthcare communications app.

The CardMedic app will help The Christie to bridge communication gaps, such as language barriers or cognitive impairments, between clinicians and patients to reduce health inequalities.

The trust is also working with CardMedic to co-create new content for its flashcard library, developing specific oncology scripts to help cancer patients communicate in spite of any barriers they may face.

The solution has been deployed across the whole trust and is now used by 100 nurses, doctors and pharmacists at four sites: Withington, Salford, Oldham and Macclesfield.

Frimley Health launches getUBetter app for musculoskeletal patients

Frimley Health NHS Foundation Trust has launched getUBetter, a new app designed to help patients with musculoskeletal (MSK) injuries and conditions manage their symptoms at home.

Created by clinicians in Emergency Care and checked by multiple GPs, physiotherapists and orthopaedic consultants, the app delivers evidence-based advice to patients so they have the right information to help them recover.

getUBetter can be used by anyone over 18 years and can offer help on all common muscle, bone and joint problems, including back, back and leg, neck, shoulder, hip, knee, ankle pain and soft tissue injury.

The app can be used by anyone who requires self-management support for a new, recurrent or long-term MSK condition, making it suitable for around 80% of Frimley Health’s MSK patients.

Tags: Digital HealthDigital Prescription and Health RecordsHealthcare Latest Trend

Get real time update about this post categories directly on your device, subscribe now.

Unsubscribe
admin

admin

Related Posts

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb
Artificial Intellegance

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

by admin
April 30, 2025
0

No refractures were reported during long-term follow-up at five years At 24-months post-implantation, 89% of patients achieved bone union Novadip...

Read moreDetails

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Sidra Medicine Publishes Impactful Study on Treatable Inherited Metabolic Disorders in Qatar

Sidra Medicine Launches Campaign Highlighting Commitment to Women’s and Children’s Health and Vision 2030

Treatment in Oman pavilion, under the Directorate General of Private Health Institutions, showcases Omani hospitals and medical institutions that rival international standards. Book your free visit now and experience excellence in healthcare!

Megatrends shaping healthcare in 2024

MEDICA 2024 + COMPAMED 2024: Know-how and innovations for the healthcare business – international and diverse with more than 6,000 exhibitors

Global Health Exhibition 2024

Stay Connected

  • 23.9k Followers
  • Trending
  • Comments
  • Latest
Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital

Dr. Raymond Liu, Vice-President, Mass General Brigham Global Advisory and Associate Radiologist for the Division of Interventional Radiology at Massachusetts General Hospital

September 15, 2024
Neonatal resuscitation: A guide to the latest equipment

Neonatal resuscitation: A guide to the latest equipment

July 16, 2024
“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”

“Revolutionizing Medical Imaging: Saudi German Hospital Dubai’s State-of-the-Art 3 Tesla MRI Machine”

October 26, 2023
GCE Medical BRINGS FULL GLOBAL SUITE OF GAS Control equipment

GCE Medical BRINGS FULL GLOBAL SUITE OF GAS Control equipment

February 6, 2024

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

0
FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine

FTC orders GoodRx to stop sharing users’ health data with advertisers, issues $1.5M fine

0
World Cancer Day: Half of Cancer Deaths Can Be Prevented

World Cancer Day: Half of Cancer Deaths Can Be Prevented

0
Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023

Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023

0
Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 2, 2025
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

February 27, 2025

Recent News

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025
Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

Rybelsus found to reduce major adverse cardiovascular events in Novo Nordisk trial

April 2, 2025
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE’s position in medical tourism

February 27, 2025

Arab Health World

This magazine is newsworthy, analytical, and informative, providing readers with unique and professional content as well as opinions and editorials that will focus on medical and healthcare development. This specialty magazine is also the choice of healthcare professionals and informed readers who need an informed monthly source of news and information in the regional healthcare industry. We aim for excellence in our scientific, health and commercial reports.

Recent News

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

Novadip releases five-year follow-up results for NVD003, regenerative treatment for severe bone non-union of lower limb

April 30, 2025
Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

Accure Therapeutics awarded a total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials

April 7, 2025

Follow Us

  • About Us
  • Cookie Policy
  • Privacy Policy
  • Terms of Use 
  • Contact

© 2023 - ArabHealthWorld all rights reserved

Welcome Back!

Sign In with Facebook
Sign In with Google
Sign In with Linked In
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
    • About Us
    • Cookie Policy
    • Privacy Policy
    • Terms of Use 
  • Business Insights
    • Accreditation
    • Healthcare Regulation
    • Infrastructure
    • Insurance
    • Leadership
    • Medical Tourism
    • Mental health
    • Medical Investment and Finance
    • Healthcare Regulation
    • Nutrition and Healthcare Latest Trend
  • Tech
    • 3DPrinting
    • Artificial Intelligence
    • Automation
    • Blockchain
    • Big Data
    • Med Tech
    • Digital Health
    • Medical devices, equipment, and hospital supplies manufacturers
  • Clinical
    • Cardiology
    • Diabetes
    • Emergency Medicine
    • Obesitrics and Guneocology
    • Obesity
    • Oncology
    • Orthopedics
    • Otolaryngology
    • Padiatrics
    • Radiology
    • Surgery
  • Laboratories
    • Clinical Chemistry
    • Diagnostics
    • Gen Therapy
    • Immunology
    • IVF
    • Labratory Accrediation
    • Labratory Management
    • MicroBiology
  • Sectors
    • Optometry
    • Dental
    • Pharma
  • Magazine
  • Media Kit

© 2023 - ArabHealthWorld all rights reserved